or
forgot password
  • cancer clinical trials in dallas, TX

  • Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    UT Southwestern Medical Center at Dallas
    Dallas, Texas 75390
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Childhood Cancer Survivor Study
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Breast Cancer
    Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
    University of Texas Southwestern
    Dallas, Texas 75390
    Neuroma, Acoustic
    Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Lymphoma
    Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
    University of Texas Southwestern Medical Center

    Trial Locations
    University of Texas Southwestern Medical Center
    University of Texas Southwest Medical Center
    Acromegaly
    Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Unspecified Childhood Solid Tumor, Protocol Specific
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Leukemia
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas

    Trial Locations
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Parkland Memorial Hospital
    Colorectal Cancer
    A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
    University of Texas Southwestern Medical Center at Dallas

    Trial Locations
    University of Texas Southwestern Medical Center at Dallas
    University of Texas Southwestern University Hospital - St. Paul
    University of Texas Southwestern University Hospital - Zale Lipshy
    Non Squamous Lung Cancer
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)
    Charles A. Cancer Center, Baylor University Medical Center
    Dallas, Texas 75246
    Chronic Graft-versus-host Disease
    Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer
    University of Texas Southwestern Medical Center

    Trial Locations
    University of Texas Southwestern Medical Center
    Ut Southwestern Medical Center
    Early Stage Breast Cancer
    A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
    InSight Diagnostic Center

    Trial Locations
    InSight Diagnostic Center
    Dermatology Treatment & Research Center, PA (DTRC)
    Menter Dermatology Research Institute
    Psoriasis
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    Texas Oncology- Sammons Cancer Center
    Dallas, Texas 75246
    Carcinoma, Squamous Cell of the Head and Neck
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Parkland Memorial Hospital

    Trial Locations
    Parkland Memorial Hospital
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Oncology
    Mary Crowley Medical City Clinic
    Texas Oncology-Dallas, PA Presbyterian
    Ovarian Cancer
    Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Neuroendocrine Tumors of Non-Pancreatic Origin, Hormone Receptor-Positive Breast Cancer
    Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
    Ut Southwestern Medical Center
    Dallas, Texas 75390
    Diffuse Intrinsic Pontine Glioma
    A Study of IMC-3G3 in Soft Tissue Sarcoma
    ImClone Investigational Site
    Dallas, Texas 75230
    Sarcoma, Soft Tissue
    Natural History Study of SCID Disorders
    University of Texas Southwestern Medical Center/Children's of Dallas
    Dallas, Texas 75390-9263
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID
    IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
    Baylor University Medical Center
    Dallas, Texas 75246
    Malignant Melanoma Stage III, Malignant Melanoma Stage IV
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
    Dermatology Treatment and Research Center

    Trial Locations
    Dermatology Treatment and Research Center
    Menter Dermatology Reserarch Institute
    Plaque Psoriasis
    Study of PX-866 and Docetaxel in Solid Tumors
    Mary Crowley Cancer Center

    Trial Locations
    Mary Crowley Cancer Center
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma
    Mary Crowley Cancer Research Center
    Dallas, Texas 75246
    Malignant Melanoma
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma